Arctic Bioscience AS (OSL:ABS) Total Long-Term Assets: kr235.34 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

OSL:ABS Arctic Bioscience AS OSL:ABS
57 GF Score
Price kr3.15
GF Value kr10.91
Valuation Possible Value Trap
! 6 Warning Signs
View Full Analysis

What is Arctic Bioscience AS Total Long-Term Assets?

Arctic Bioscience AS OSL:ABS +2.94% 57 Total Long-Term Assets is kr235.34 Mil as of Dec. 2025. GuruFocus rates OSL:ABS with a GF Score™ of 57/100 and a GF Value™ of kr10.91 (Possible Value Trap). The stock has 6 warning signs investors should review.

Total Long-Term Assets includes Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets. Arctic Bioscience AS's Total Long-Term Assets for the quarter that ended in Dec. 2025 was kr235.34 Mil.

Arctic Bioscience AS Total Long-Term Assets Related Terms

Arctic Bioscience AS Total Long-Term Assets Historical Data

* Premium members only.

The historical data trend for Arctic Bioscience AS's Total Long-Term Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Arctic Bioscience AS Total Long-Term Assets Chart

Arctic Bioscience AS Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Long-Term Assets
Get a 7-Day Free Trial 74.54 129.38 167.10 221.86 235.34

Arctic Bioscience AS Semi-Annual Data
Dec18 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Total Long-Term Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 167.10 198.46 221.86 235.13 235.34
OSL:ABS
57GF Score
Arctic Bioscience AS OSL:ABS
Total Long-Term Assets is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Arctic Bioscience AS Total Long-Term Assets Calculation

Total Long-Term Assets are the sum of the carrying amounts of all assets that are expected to be realized in cash, sold or consumed longer than one year. It includes Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets.

Frequently Asked Questions Learn more about Total Long-Term Assets →
What does a Total Long-Term Assets of kr235.34 Mil mean?
Arctic Bioscience AS (OSL:ABS) has a Total Long-Term Assets of kr235.34 Mil as of Dec. 2025. Total Long-Term Assets are assets that are expected to be realized in cash, sold or consumed longer than one year. View historical data on Arctic Bioscience AS and its competitors.
Is Arctic Bioscience AS's Total Long-Term Assets too high?
Arctic Bioscience AS's current Total Long-Term Assets is kr235.34 Mil. Overall, Arctic Bioscience AS has a GF Score™ of 57/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Arctic Bioscience AS's Total Long-Term Assets compare to VRTX and REGN?
Arctic Bioscience AS's Total Long-Term Assets of kr235.34 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Long-Term Assets for a Biotechnology company?
A good Total Long-Term Assets depends on the Biotechnology industry context. However, Total Long-Term Assets should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Long-Term Assets mean?
A high Total Long-Term Assets can signal that a stock is expensive relative to its fundamentals. Total Long-Term Assets are assets that are expected to be realized in cash, sold or consumed longer than one year. View historical data on Arctic Bioscience AS and its competitors. Arctic Bioscience AS's current Total Long-Term Assets is kr235.34 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Arctic Bioscience AS stock overvalued right now?
Based on GuruFocus' analysis, Arctic Bioscience AS (OSL:ABS) is currently considered Possible Value Trap. The stock's GF Value™ is kr10.91, compared to a current price of kr3.15 — trading 71.1% below its estimated fair value. The current Total Long-Term Assets is kr235.34 Mil. Arctic Bioscience AS's overall GF Score™ is 57/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Long-Term Assets calculated?
Total Long-Term Assets is calculated from a company's financial statements. For Arctic Bioscience AS (OSL:ABS), the current Total Long-Term Assets is kr235.34 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Arctic Bioscience AS (OSL:ABS) Overvalued in 2026?

Based on GuruFocus' analysis, Arctic Bioscience AS stock appears to be undervalued. The current stock price of kr3.15 is trading 71.1% below its estimated GF Value™ of kr10.91. GuruFocus considers Arctic Bioscience AS to be Possible Value Trap.

Key valuation signals for OSL:ABS:

  • Total Long-Term Assets: kr235.34 Mil
  • GF Value™: kr10.91 vs. price of kr3.15 (71.1% below fair value)
  • GF Score™: 57/100 with 6 warning signs

No single metric tells the full story. See the OSL:ABS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Arctic Bioscience AS Business Description

Other Exchanges 9TD:Germany
Address Industrivegen 42, Orsta, NOR, 6155
Arctic Bioscience AS is a clinical-stage biotechnology company working to develop drug candidates within the areas of autoimmune and inflammatory diseases. It is developing pharmaceutical and commercializing nutraceutical products based on bioactive marine compounds, including lipids essential to maintaining cell membranes. The company's proprietary extraction technology is used to extract membrane fats from marine raw materials, such as herring roe and algae. Geographically, the company operates in Norway, the Americas, Europe, and APAC, with the majority of the revenue derived from the Americas.
57GF Score

Get the complete analysis for OSL:ABS

Total Long-Term Assets is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr3.15
Price
kr10.91
GF Value